AGP Picks
View all

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on November 19, 2026

Harmony Biosciences to Participate in Upcoming Investor Conferences
VivoSim Labs Signs Seven-Figure Agreement with a Top-10 Global Pharmaceutical Company; Expects to Exceed Its 500%+ Revenue Growth Guidance for Fiscal 2027
ITM and AtomVie Global Radiopharma Enter Supply Agreement for n.c.a. Lutetium-177
IRulya Therapeutics to Participate in the 9th Annual Evercore Healthcare Conference
Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback
Altimmune to Participate in the 9th Annual Evercore Healthcare Conference
Phathom Pharmaceuticals Marks GERD Awareness Week 2026 by Urging Americans to Take Frequent Heartburn Seriously
New National Survey Found Many People With Sleep Apnea Struggle to Stay on Treatment
Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access
HYTN Innovations Inc. and Peptide Development Labs Inc. Announce Closing of the Arrangement and Concurrent Financing
Bluesight Tracks 340B Dollars from Invoice to Rebate as 2027 Brings New Financial and Operational Challenges
Chemomab Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update
Actinogen pivotal Alzheimer’s disease trial demonstrates clinical benefit in older patients with mild to moderate disease, favorable safety profile and trends towards benefit in the overall population
Clearmind Medicine Expands PTSD Patent Portfolio with Hong Kong Patent Application Publication
Medicus Pharma Regains Compliance with Nasdaq Minimum Equity Requirement for Continued Listing
Conavi Medical Highlights Commercial Launch and Significant Growth Potential in Shareholder Letter
Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)
Evaxion announces strategy and business update and third quarter 2026 financial results
In a Co-Managed Customer Support Model, Growing Companies Can Keep Control of Training While a Partner Runs Staffing
Adagene Announces First Patient Dosed in Phase 1 Study of ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Yemen Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.